Abdominal Superficial Subcutaneous Fat you.

OBJECTIVE d Unlike visceral adipose tissue (VAT), the association between subcutaneous adipose tissue (SAT) and obesity-related morbidity is controversial. In patients with type 2 dia- betes, we assessed whether this variability can be explained by a putative favorable, distinct association between abdominal super fi cial SAT (SSAT) (absolute amount or its proportion) and cardiometabolic parameters. , mean circumference. Fasting plasma 1c of waist circumference, %SSAT signi cantly with HbA

[1]  R. Pozzi-mucelli,et al.  Predictors of Ectopic Fat Accumulation in Liver and Pancreas in Obese Men and Women , 2011, Obesity.

[2]  M. Budoff,et al.  Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. , 2011, The American journal of medicine.

[3]  D. Dumitrascu,et al.  Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus , 2011, Acta Diabetologica.

[4]  J. Manson,et al.  Update in hormone therapy use in menopause. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  K. Fox,et al.  Anthropometric measurements and diabetes mellitus: clues to the "pathogenic" and "protective" potential of adipose tissue. , 2010, Metabolic syndrome and related disorders.

[6]  Yoshihiko Takahashi,et al.  Associations of Visceral and Subcutaneous Fat Areas With the Prevalence of Metabolic Risk Factor Clustering in 6,292 Japanese Individuals , 2010, Diabetes Care.

[7]  B. Cha,et al.  The effect of rosiglitazone on insulin sensitivity and mid‐thigh low‐density muscle in patients with Type 2 diabetes , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[8]  R. Vasan,et al.  Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot? , 2009, Diabetes Care.

[9]  Stanley Heshka,et al.  Adipose tissue distribution is different in type 2 diabetes. , 2009, The American journal of clinical nutrition.

[10]  D. Mozaffarian,et al.  Trans fatty acids: effects on cardiometabolic health and implications for policy. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  Jonathan Krakoff,et al.  Distribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex‐specific Manner , 2008, Obesity.

[12]  S. Weisnagel,et al.  Regional body fat distribution and metabolic profile in postmenopausal women. , 2008, Metabolism: clinical and experimental.

[13]  Udo Hoffmann,et al.  Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.

[14]  R. Bhopal,et al.  Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. , 2007, International journal of epidemiology.

[15]  O. Hamdy,et al.  Metabolic obesity: the paradox between visceral and subcutaneous fat. , 2006, Current diabetes reviews.

[16]  S. Kritchevsky,et al.  Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study , 2005, Diabetologia.

[17]  D. Shahar,et al.  Selection of food items for inclusion in a newly developed food-frequency questionnaire , 2004, Public Health Nutrition.

[18]  A. Häkkinen,et al.  Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk , 2004, Diabetologia.

[19]  E. Rimm,et al.  Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. , 2003, The American journal of clinical nutrition.

[20]  P. Dupont,et al.  Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women. , 2003, Obesity research.

[21]  Jimmy D Bell,et al.  Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue , 2003, International Journal of Obesity.

[22]  R. Huupponen,et al.  Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. , 2003, Diabetes.

[23]  Y. Miyazaki,et al.  Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. , 2002, American journal of physiology. Endocrinology and metabolism.

[24]  M. Laakso,et al.  Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention , 2001, Journal of internal medicine.

[25]  F. Pi-Sunyer,et al.  Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. , 2001, American journal of physiology. Endocrinology and metabolism.

[26]  B. Goodpaster,et al.  Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. , 2000, American journal of physiology. Endocrinology and metabolism.

[27]  B. Balkau,et al.  Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women’s healthier cardiovascular risk profile. The D.E.S.I.R. Study , 1999, International Journal of Obesity.

[28]  B. Goodpaster,et al.  Subcutaneous Abdominal Fat and Thigh Muscle Composition Predict Insulin Sensitivity Independently of Visceral Fat , 1997, Diabetes.

[29]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[30]  P. Björntorp.  "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. , 1990, Arteriosclerosis.